DOI:
10.1055/s-00035331
Revista Urología Colombiana / Colombian Urology Journal
LinksClose Window
References
Bellmunt J, de Wit R, Vaughn DJ. , et al; KEYNOTE-045 Investigators.
Pembrolizumab as second-line therapy for advanced urothelial carcinoma.
N Engl J Med 2017;
376 (11) 1015-1026
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.